A Commentary on

Nagpal D, Ibraimova L, Ohinmaa A, Levin L.

The cost-effectiveness of tooth preservation vs implant placement in severe periodontal disease patients: a systematic review. Quintessence Int. 2024; https://doi.org/10.3290/j.qi.b4500025.

GRADE Rating:

Commentary

Severe periodontitis affects approximately 11% of the global population, as indicated by the Global Burden of Disease Study 2017 and the European Federation of Periodontology (EFP)1. This condition leads to the loss of periodontal support, impairing chewing ability and negatively impacting oral health-related quality of life2. Treatment success centers on several factors including home care, dental hygiene, risk management, disease control, and supportive periodontal therapy (SPT)3. Despite its chronic nature, regular SPT is required to maintain long-term stability4. Modern dental implants are popular for replacing missing teeth, but accurate diagnosis and prognosis assessment are necessary before deciding on treatment5. Despite high survival rates, implants can fail, especially with peri-implant inflammations like mucositis and peri-implantitis6,7. Levin and Halperin-Sternfeld found implant survival does not exceed that of properly maintained natural teeth8. Thus, economic evaluations are fundamental for deciding treatment strategies, considering costs and outcomes, making it an area requiring further investigation. The reviewed meta-analysis by Nagpal et al.9 aimed to determine the cost-effectiveness of periodontal treatment versus dental implants for periodontally compromised teeth, considering both clinical and economic aspects.

The primary strength of this systematic review is its adherence to the PRISMA statement guidelines, providing a robust and transparent methodological framework. The comprehensive search strategy across 4 databases up to summer 2023 supported the thoroughness and reliability of the review. Additionally, the inclusion criteria were well-defined, including various study designs (RCTs, SRs, narrative reviews, retrospective studies, cross-sectional studies, case series, and case reports) which allowed for a broad assessment of the available evidence.

The independent screening and quality assessment by two reviewers, with a third reviewer resolving conflicts, minimized bias and confirmed the reliability of the selection process. The use of the JBI critical appraisal tools for evaluating the methodological quality of included studies further strengthened the review’s findings10. The detailed data extraction process, capturing key aspects such as study design, patient demographics, treatment modalities, and economic models, provided a comprehensive overview of the studies’ characteristics and outcomes.

A significant limitation of this review is the heterogeneity among the included studies, which did not permit conducting a meta-analysis. This variability in study designs, populations, and follow-up durations complicates direct comparisons and generalizations of the findings. Additionally, the review predominantly included retrospective studies, which may be prone to selection and recall bias. The lack of randomized clinical trials with long-term follow-up also limits the strength of the evidence.

Future research should conduct robust RCTs with long-term follow-up to provide clear evidence on the cost-effectiveness of preserving teeth versus dental implants in severe periodontal disease. Standardized methodologies and consistent outcome definitions are needed for reliable comparisons. Additionally, economic evaluations should include broader costs and patient-reported quality of life and functional outcomes11,12.

To sum up, while the current review determined the cost-effectiveness of periodontal treatment versus dental implants, the findings are limited by the heterogeneity and predominance of retrospective studies. Despite these limitations, the review identified the potential for periodontal treatment to be a cost-effective alternative to dental implants, particularly when considering long-term maintenance and complication costs. Thus, future research should aim to address the identified limitations and provide more robust evidence to inform clinical decision-making.